Comparing the current results to its competitors, Harvard Bioscience Inc reported Revenue decrease in the 1 quarter 2026 year on year by -4.44 %, despite the revenue increase by the most of its competitors of 5.01 %, recorded in the same quarter.
Harvard Bioscience Inc , slower than the average decrease reported by the company's competitors of -1.84 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -1.84 %
Harvard Bioscience Inc 's Comment on Competition and Industry Peers
The company operates in highly competitive markets for life science research tools, facing competitors with greater financial, operational, sales, and marketing resources, as well as more experience in research and development and commercialization. Competitors may have broader product offerings, greater name recognition, and often employ discounting strategies. There is a risk that competitors or others could develop new technologies that render the company's products obsolete. The company competes based on product performance, quality, reliability, speed, technical support, price, and delivery, but cannot guarantee successful enhancement of its technologies to remain competitive against emerging technologies. Numerous competitors exist across the company's product lines.
Agilent Technologies Inc. operates a business model centered on delivering innovative measurement solutions across industries like life sciences, diagnostics, and chemical analysis. Their revenue primarily comes from sales of instruments, software, and consumables, supplemented by support services. The company emphasizes strong partnerships and collaborations to enhance their market presence and influence.
Thermo Fisher Scientific Inc operates as a global leader in scientific research and services by delivering an extensive range of high-quality scientific instruments, reagents, consumables, and software solutions tailored to industries such as healthcare, pharmaceuticals, biotechnology, academia, and government. The company enhances its value proposition through a comprehensive suite of services, including laboratory outsourcing, scientific consulting, and data analysis, which help streamline research and development processes for its customers. By leveraging advanced technology and deep industry expertise, Thermo Fisher empowers researchers and organizations to drive innovation and accelerate scientific discovery.
Rapid Micro Biosystems Inc has a business model centered around providing automated microbial detection and enumeration solutions for pharmaceutical companies, ensuring streamlined and efficient quality control processes. Their innovative technology enables rapid detection of microbial contamination in products, reducing the need for manual intervention and accelerating time-to-results for manufacturers.
Mettler toledo International Inc Share Performance
+0.45%
Over The Past 5 Days
Mettler toledo International Inc
Profile
Mettler Toledo International Inc. operates on a business model that focuses on providing high-quality precision instruments and solutions tailored for various industries, including pharmaceuticals, food production, and laboratory research. The company emphasizes innovation and customer-centric service, delivering advanced technology and software alongside its instruments to enhance operational efficiency and accuracy. Additionally, Mettler Toledo generates recurring revenue through maintenance services, calibration, and consumables associated with its products, fostering long-term relationships with its clients.
Sources:
Harvard Bioscience Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Harvard Bioscience Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
